急性酮体补充下ZDF大鼠心脏酮体代谢:一种2型糖尿病心力衰竭模型
研究采用[13N]氨水PET评估瘦型与糖尿病肥胖ZDF大鼠的冠状动脉血流储备(CFR),并用[11C]乙酰乙酸PET在静息和负荷条件下评估基线及急性口服酮酯补充后的心脏酮体代谢。T2D组CFR受损(1.8±0.5 vs 1.4±0.2,p<0.05);补充后血酮升高2倍以上;T2D组静息摄取在补充后降低20%(p<0.05),负荷/静息比值升至CTRL水平;负荷下代谢负荷/静息比值仅在T2D组升高(1.25±0.29,p=0.03)。结论提示T2D大鼠心脏酮体代谢在心力衰竭过程中受损,酮体补充可能具有恢复心脏储备的潜力。
要点
- T2D组CFR较CTRL组降低(1.8±0.5 vs 1.4±0.2,p<0.05),提示心力衰竭发展。
- 酮体补充后血酮升高2倍以上;T2D组静息[11C]AcAc心脏摄取降低20%(p<0.05)。
- T2D组补充后负荷/静息比值升至CTRL水平;负荷下代谢负荷/静息比值仅T2D组升高(1.25±0.29,p=0.03)。
核心结论
- 在T2D伴CFR受损的大鼠模型中,可用[11C]AcAc PET在静息和负荷条件下测量伴或不伴急性酮体补充时的酮体代谢变化。
- 研究结果提示T2D大鼠心脏酮体代谢在心力衰竭过程中受损,酮体补充可能具有恢复心脏储备的潜力。
研究设计与样本
- 研究纳入六只瘦型ZDF大鼠(CTRL)和六只糖尿病肥胖ZDF大鼠(T2D),采用[13N]NH3心脏PET评估冠状动脉血流储备(CFR)。
- 采用[11C]AcAc PET在静息和负荷条件下评估酮体代谢,分别在基线和急性外源性酮酯口服补充后。
- 同时评估血液生化、心脏功能和血流动力学参数。
主要发现
- CFR在T2D模型受损(CTRL:1.8±0.5;T2D:1.4±0.2,p<0.05),提示T2D模型发生心力衰竭。
- 酮体补充后血酮升高2倍以上。
- [11C]AcAc心脏酮体摄取在CTRL组补充与不补充时相似,且这些值高于T2D大鼠。
- T2D组静息摄取在酮体补充后较不补充降低20%(p<0.05),负荷条件下补充与不补充保持不变。
- 因静息摄取降低,补充后负荷/静息比值升至CTRL观察到的水平;CTRL组负荷下[11C]AcAc心脏酮体代谢略降低,T2D组无此变化;补充后代谢负荷/静息比值仅T2D组升高(1.25±0.29,与基线相比p=0.03)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In non-insulin-dependent, type 2, diabetes mellitus (T2D), glucose metabolism is compromised, and the heart loses its metabolic flexibility. The Zucker Diabetic Fatty rat (ZDF) model, which replicates the pathophysiology of T2D in patients, shows that as T2D progresses so does heart failure. Heart ketone metabolism seems to play a role in mitigating the heart failure process. This study assesses ketone metabolism in a ZDF heart failure model using cardiac PET imaging. METHODS: Six lean ZDF rats (CTRL) and six diabetic obese ZDF rats (T2D) were evaluated for coronary flow reserve (CFR) using [13N]ammonia ([13N]NH3) cardiac PET. In addition, rats were evaluated with [11C]acetoacetate ([11C]AcAc) PET during rest and stress conditions to assess ketone metabolism, both at baseline and under an acute exogenous ketone ester oral supplementation. Blood chemistry, cardiac function and hemodynamic parameters were also evaluated under these conditions. RESULTS: CFR was impaired in the T2D model (CTRL: 1.8 ± 0.5; T2D: 1.4 ± 0.2, p < 0.05) suggesting the development of heart failure in the T2D model. Blood ketones increased more than 2-fold after supplementation. The [11C]AcAc heart ketone uptake values with and without ketone supplementation were similar for the CTRL group, and these values were higher than for T2D rats. For the T2D group, the uptake decreased by 20% at rest under ketone supplementation vs. no supplementation (p < 0.05) and remained unchanged under stress with and without supplementation. Because of this decrease at rest, the stress/rest ratio after supplementation increases to the level observed in CTRL. [11C]AcAc heart ketone metabolism showed a slight decrease under stress for the CTRL group, but not for the T2D. Under ketone supplementation, the metabolism stress/rest ratio increased only in T2D (1.25 ± 0.29, p = 0.03 compared to baseline). CONCLUSION: In a rat model of T2D and CFR impairment, we were able to measure changes in ketone metabolism using [11C]AcAc PET at rest and under stress with and without acute ketone supplementation. Our findings suggest that the heart ketone metabolism of T2D rats is impaired during the heart failure process. Ketone supplementation may have the potential to restore this cardiac reserve.
引用
- Croteau E, Richard G, Prud'Homme P, et al. Heart ketone metabolism under acute ketone supplementation in ZDF rats, a type 2 diabetes heart failure model. EJNMMI Res. 2025. PMID: 40087189. doi:10.1186/s13550-025-01215-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。